baber/WOPTO huggingface dataset:
Patent CA-3097695-A1 (CA)
Title: Systems and methods for using namespaces to access computing resources
Inventor: BEREDIMAS IOANNIS
IPC: H04L29/06
Filed: 2019-07-01
Abstract: Systems and methods described herein provide for building policies using namespaces. A device may receive a request to access a resource in a computing environment. The request may include one or more attributes. The device may identify a set of namespaces having domain-specific policy grammar to generate domain-specific policies.  The device may determine a namespace from the identified set of namespaces which corresponds to the one or more attributes of the request. The device may generate, using domain-specific policy grammar of the determined namespace, a domain-specific policy to apply to the request.
Patent CA-3099113-A1 (CA)
Title: Safety constraints for a control algorithm-based drug delivery system
Inventor: O'CONNOR JASON
IPC: G16H20/17
Filed: 2019-05-03
Abstract: Disclosed are a system, methods and computer-readable medium products that provide safety constraints for an insulin-delivery management program. Various examples provide safety constraints for a control algorithm-based drug delivery system that provides automatic delivery of a drug based on sensor input. Glucose measurement values may be received at regular time intervals from a sensor. A processor may predict future glucose values based on prior glucose measurement values. The safety constraints assist in safe operation of the drug delivery system during various operational scenarios. In some examples, predicted future glucose values may be used to implement safety constraints that mitigate under-delivery or over-delivery of the drug while not overly burdening the user of the drug delivery system and without sacrificing performance of the drug delivery system. Other safety constraints are also disclosed.
Patent CA-3099704-A1 (CA)
Title: Methods of treating phenylketonuria
Inventor: BERGUIG GEOFFREY
IPC: A61P3/00
Filed: 2019-05-08
Abstract: Provided herein are methods of treating phenylketonuria by normalizing levels of amino acids, neurotransmitters, and neurotransmitter metabolites in a subject having phenylketonuria.
Patent CA-3101050-A1 (CA)
Title: Antiproliferative compounds and bispecific antibody against bcma and cd3 for combined use
Inventor: PIERCE DANIEL W
IPC: A61P35/00
Filed: 2019-05-22
Abstract: Provided herein is are methods of using 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l- oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-l-yl)-3-fluorobenzonitrile, or an enantiomer, a mixture of enantiomers, a tautomer, or a pharmaceutically acceptable salt thereof and a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3e (CD3) provided herein, in treating, preventing or managing multiple myeloma.
Patent CA-3101678-A1 (CA)
Title: Method for determining reserved tones and transmitter for performing papr reduction using tone reservation
Inventor: OH YOUNG-HO
IPC: H04L27/26
Filed: 2016-06-09
Abstract: ABS TRACT A method of determining reserved tones to be used for reduction of a peak to average power ratio (PAPR) of a signal includes: randomly selecting carrier indices for the reserved tones and generating a kernel signal based on the randomly selected carrier indices for the reserved tones; calculating a comparison reference average value of the kernel signal, comparing the calculated comparison reference average value with a prestored comparison reference average value, and preliminarily determining carrier indices of the reserved tones based on the comparison; re-arranging an order of the preliminarily determined carrier indices of the reserved tones; calculating comparison reference average values of kernel signals generated by changing each of the re-arranged carrier indices of the reserved tones, and finally determining carrier indices of the reserved tones which generate a kerneal signal having the smallest comparison reference average value among the comparison reference average values as indices of the reserved tones. Date Recue/Date Received 2020-12-04
Patent CA-3109435-A1 (CA)
Title: Provenance and illicit product control system
Inventor: MOHAMED IQBAL
IPC: G06Q10/08
Filed: 2019-08-23
Abstract: A method for provenance and illicit product control involves generating a unique identifier for a product unit, generating a unique identifier for a subunit of the product unit, and recording locations of the product unit and the subunit of the product unit to a blockchain in association with the unique identifiers. The blockchain includes linked data blocks containing sequential records of locations and quantities of product units and subunits of the product units moved through a product distribution supply chain. The method further involves tracking movement of the product unit and the subunit of the product unit through the product distribution supply chain, detecting an inconsistency between a record on the blockchain and movement of the product unit or the subunit of the product unit through the product distribution supply chain and outputting an indication of the inconsistency.
Patent CA-3110168-A1 (CA)
Inventor: BERTRAND CHLOE
IPC: D04B21/16
Filed: 2019-08-16
Abstract: La présente invention concerne un tissu de renforcement hybride qui comprend des fibres de verre et des fibres de carbone. Le tissu de renforcement hybride peut être aisément infusé à une vitesse d'infusion acceptable, sans nécessiter que les câbles de fibres de carbone utilisés pour former le tissu de renforcement hybride soient étalés ou préimprégnés de résine. Par conséquent, le tissu permet un processus d'infusion efficace en une étape (c'est-à-dire, dans le moule) pendant la formation d'une pièce composite.
Patent CA-3110884-A1 (CA)
Inventor: LO YUK-MING DENNIS
IPC: C12Q1/68
Filed: 2020-08-17
Abstract: Systems and methods for using determination of base modification in analyzing nucleic acid molecules and acquiring data for analysis of nucleic acid molecules are described herein. Base modifications may include methylations. Methods to determine base modifications may include using features derived from sequencing. These features may include the pulse width of an optical signal from sequencing bases, the interpulse duration of bases, and the identity of the bases. Machine learning models can be trained to detect the base modifications using these features. The relative modification or methylation levels between haplotypes may indicate a disorder. Modification or methylation statuses may also be used to detect chimeric molecules.
Patent CA-3112885-A1 (CA)
Inventor: STUBE ALICIA
IPC: A23L7/17
Filed: 2019-10-29
Abstract: A crisp proteinaceous food product in which egg white proteins constitute the majority of total proteins present is described. The food product has a bulk density of from 120 to ~500 g/L and includes water, expanded starch, and denatured proteins. Ovalbumin constitutes at least 33% (w/w) of the proteins. Expanded starch can constitute at least 35% (w/w) of the food product.
Patent CA-3114258-A1 (CA)
Inventor: WU YUMIN
IPC: H04W28/06
Filed: 2019-09-27
Abstract: La présente invention concerne un procédé de traitement d'informations de capacité de dispositif terminal, un dispositif terminal et un dispositif côté réseau. Le procédé comprend : lorsque la taille des informations de capacité de dispositif terminal est supérieure à la valeur maximume de la taille de SDU PDCP, l'envoi d'un premier message à un dispositif côté réseau, le premier message comprenant des premières informations, et les premières informations comprenant des informations utilisées pour indiquer que la taille des informations de capacité de dispositif terminal est supérieure à la valeur maximale de la taille de SDU PDCP.
Patent CA-3114723-A1 (CA)
Title: Systems and methods for message transmission and retrieval using blockchain
Inventor: ADLURI MAHENDER
IPC: H04L9/32
Filed: 2019-08-30
Abstract: Systems and methods for message transfer and retrieval are provided. According to some aspects, message information is received from a sender, and a message can be created based on the received message information. A hash of the message and transaction information related to the message can be generated and provided to a current block in a blockchain. The message is transferred or otherwise provided to a receiver, and upon receipt and validation of authentication information from the receiver, access to the received message is provided to the receiver. A hash of the received message and additional transaction information related to the received message is generated and provided to a current block in the blockchain. Other aspects also are provided.
Patent CA-3114807-A1 (CA)
Title: Fastening device for assembly and quick release between objects
Inventor: VALEMBOIS GUY
IPC: B64G1/22
Filed: 2019-09-26
Abstract: Fastening device for assembly and quick release between objects, formed of a retaining means (3) designed to retain, before releasing, an attachment element (R), and consisting of bringing together, around a dockable portion of said attachment element, a plurality of separable parts (30) held close together around said attachment element (R) by means of at least one disengagable preloading mechanism (2) that consists of a link wound around the separable parts (30) in order to hold them closed on the attachment element, which has the appearance of a ribbon wound in a spiral and has spring properties. The ribbon (2) has a non-constant thickness, i.e. the thickness decreases from the inside towards the outside of the spiral, said thickness decreasing with the angle of the spiral. It is manufactured as such, in its final form, by a manufacturing process employing either the removal of material by machining, or by aggregation of material.
Patent CA-3115296-A1 (CA)
Inventor: TULSYAN ADITYA
IPC: G01N21/84
Filed: 2019-10-23
Abstract: L'invention concerne un procédé de surveillance et/ou de commande d'un processus biopharmaceutique qui consiste à déterminer un point d'interrogation associé au balayage du processus par un système de spectroscopie (par exemple, un système de spectroscopie Raman), et à interroger une base de données d'observation contenant des ensembles de données d'observation associés à des observations passées de processus biopharmaceutiques. Chaque ensemble de données d'observation comprend des données spectrales et une mesure analytique réelle correspondante. L'interrogation de la base de données d'observation consiste à sélectionner en tant que données d'apprentissage, parmi les ensembles de données d'observation, les ensembles de données qui satisfont un ou plusieurs critères de pertinence par rapport au point d'interrogation. Le procédé consiste également à utiliser les données d'apprentissage sélectionnées pour étalonner un modèle local spécifique du processus biopharmaceutique. Le modèle local (par exemple, un modèle de processus gaussien) est entraîné pour prédire des mesures analytiques sur la base d'entrées de données spectrales. Le procédé comprend également l'utilisation du modèle local pour prédire une mesure analytique du processus biopharmaceutique.
Patent CA-3116641-A1 (CA)
Title: Pompe centrifuge a levitation magnetique
Inventor: GHELLI NICOLA
IPC: A61M60/804
Filed: 2019-10-16
Abstract: La pompe centrifuge à lévitation magnétique comprend : un corps creux (2) pourvu d'au moins un raccord d'entrée (3) et d'au moins un raccord de sortie (4) pour le sang; un élément de rotor (8), logé à l'intérieur du corps creux (2) et comprenant au moins une partie magnétique (9), l'élément de rotor (8) pouvant être commandé en rotation autour d'un axe de rotation (X), sans contact, par un élément de stator pouvant être associé au corps creux (2), l'élément de rotor (8) comprenant au moins un corps en rotation(10), qui définit une surface supérieure (12) supportant plusieurs lames (11) qui sont adaptées pour transporter le sang vers le raccord de sortie (4); la surface supérieure (12) ayant une forme sensiblement concave et le corps en rotation (10) comprend au moins un trou traversant (30) qui est positionné le long de l'axe de rotation (X).
Patent CA-3117018-A1 (CA)
Inventor: SAHIN FIKRETTIN
IPC: A61K36/30
Filed: 2019-01-09
Abstract: The present invention relates to a medicine developed for treatment of psoriasis and production method thereof. This medicine for treatment of psoriasis developed in the scope of the present invention comprises tallow, larch resin, beeswax, gum mastic, propolis, Alkanna tinctoria, alum and Juniper tar.
Patent CA-3117593-A1 (CA)
Title: Mosquito attractant formulations and uses thereof
Inventor: IGNELL RICKARD
IPC: A01N25/00
Filed: 2019-11-19
Abstract: There is provided herein a mosquito attractant formulation comprising an effective amount of each of the components 3-octanone, heptanal, benzaldehyde, sulcatone, octanal, nonanal and decanal, and uses of the same. There is also provided combination products, kits-of-parts and devices comprising such formulations.
Patent CA-3119188-A1 (CA)
Inventor: SCHMITT THOMAS M
IPC: C07K14/725
Filed: 2019-11-08
Abstract: Binding proteins specific for Msln20-28 or Msln530-538 peptides are provided herein. Polynucleotides encoding the binding proteins, as well as compositions and recombinant host cells comprising the binding proteins or polynucleotides are also provided. The compositions and recombinant host cells may be used to treat a subject having mesothelioma, pancreatic cancer, ovarian cancer, lung cancer, a cancer wherein an Msln20-28 peptide is expressed on a tumor cell of the cancer, or a cancer wherein an Msln530-538 peptide is expressed on a tumor cell of the cancer.
Patent CA-3120221-A1 (CA)
Title: Process for preparation of 5-bromo-1,3-dichloro-2-fluoro-benzene
Inventor: KOERBER KARSTEN
IPC: C07C17/35
Filed: 2019-11-25
Abstract: The invention relates to a process for the preparation of 5-bromo-1,3-dichloro-2-fluoro-benzene by diazotization and reduction of 6-bromo-2,4-dichloro-3-fluoro-aniline, which is obtained by bromination of 2,4-dichloro-3-fluoro-aniline, which is obtained by reduction of 1,3- dichloro-2-fluoro-4-nitro-benzene, and a process for preparing active compounds of formula V (Formula V) wherein the variables are defined in the specification by further transforming 5-bromo-1,3- dichloro-2-fluoro-benzene obtained from 2,4-dichloro-3-fluoro-aniline by the process accord- ing to the invention.
Patent CA-3121408-A1 (CA)
Inventor: ZENG MI
IPC: C07D451/14
Filed: 2019-11-29
Abstract: La présente invention concerne des dérivés hétéroaromatiques destinés à être utilisés comme régulateurs, leur procédé de préparation et leur utilisation. En particulier, l'invention concerne des composés représentés par la formule générale (I), leurs procédés de préparation, des compositions pharmaceutiques comprenant lesdits composés, et leur utilisation en tant qu'inhibiteurs de Janus kinase dans le traitement de maladies inflammatoires et de maladies associées à des tumeurs.
Patent CA-3122453-A1 (CA)
Inventor: CHOU JINGYU
IPC: A01N43/80
Filed: 2019-11-29
Abstract: La présente invention concerne une composition herbicide stable, la composition comprenant des principes actifs A et B. Le composant A est choisi parmi un composé représenté par la formule générale (I) suivante. Le composant B est choisi parmi le glyphosate et des sels ou esters appropriés de celui-ci. Lorsqu'une préparation solide est préparée, le composant actif A est d'abord adsorbé à l'aide d'un support d'adsorption, et un produit d'adsorption est ensuite mélangé au composant B, à un promoteur et à une charge pour obtenir une préparation solide stable.
Patent CA-3122557-A1 (CA)
Title: Joint replacement alignment guides, systems and methods of use and assembly
Inventor: LEE DANIEL J
IPC: A61B17/17
Filed: 2019-12-13
Abstract: Instruments, devices, systems and methods for maintaining, correcting and/or fusing joint deformities are disclosed. The system includes a first translation mechanism, a second translation mechanism coupled to the first translation mechanism, and a third translation mechanism coupled to the second translation mechanism, and a tower coupled to the third translation mechanism. Methods of assembling and using the alignment guides for maintaining, correcting and/or fusing joint deformities are also disclosed.
Patent CA-3125581-A1 (CA)
Inventor: NOYES PETER
IPC: G06F3/048
Filed: 2019-12-27
Abstract: L'invention concerne des systèmes et des procédés de synchronisation d'une modification de balisage de document sur une pluralité de dispositifs. Un procédé comprend l'abonnement à un ou plusieurs événements se produisant dans une première application de balisage de document et la réception d'une notification indiquant une modification apportée à un marquage de document dans la première application de balisage de document. Un objet de balisage associé au balisage de document modifié peut être extrait et traduit en un objet de balisage compatible au croisement. L'objet de balisage compatible au croisement est transmis à une seconde application de balisage de document à rendre et à afficher à un utilisateur.
Patent CA-3128739-A1 (CA)
Inventor: BISSELL ANDREW JOHN
IPC: C09K5/14
Filed: 2020-02-10
Abstract: There is herein described phase change materials (PCMs) comprising at least one or a plurality (e.g. a mixture) of tetrafluoroborate salts that are capable of undergoing a solid to solid phase transition. In particular, there is described phase change materials (PCMs) comprising at least one or a plurality (e.g. a mixture) of tetrafluoroborate salts where there is at least one tetrafluoroborate salt or a plurality of tetrafluoroborate salt which have a solid to solid phase transition. The tetrafluoroborate salt may comprise at least one anion or a plurality of the same or different anions of tetrafluoroborate (e.g. BF4-). The PCM may have a solid to solid phase change in the region of about -270°C to about 3,000°C, about -50°C to about 1,500°C, about 0°C to about 1,000°C, or about 0°C to about 500°C temperature range.
Patent CA-3128961-A1 (CA)
Title: Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
Inventor: CHU HANG
IPC: C07D487/04
Filed: 2020-03-20
Abstract: Compounds for use in treating or preventing human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following formula (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R<sup>1</sup>, R<sup>2</sup>, L, W<sup>1</sup>, W<sup>2</sup>, X, Y, and Z are as defined herein. Methods associated with the preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
Patent CA-3131208-A1 (CA)
Inventor: BARI SYED
IPC: G06F16/21
Filed: 2021-09-17
Abstract: Il est décrit des systèmes et des procédés de conception dun réseau de confiance de dispositifs munis dun système de détection dintrusion (SDI) utilisant la technologie chaîne de blocs de l'Internet des objets (IDO). La méthode comprend linscription dun appareil IDO sur un ensemble de canaux de réseaux de la chaîne de blocs. Lensemble de canaux de réseaux de la chaîne de blocs comprend un canal dauthentification, une voie de transmission de données, un canal à distance, un canal de sécurité connectés à des serveurs correspondants dans le but deffectuer des opérations spécialisées, comme lauthentification du dispositif, la gestion de données, les opérations à distance/le contrôle d'accès et la détection dune intrusion. À la suite dune authentification réussie, le dispositif IDO est en mesure daccéder, de stocker et dextraire des données stockées sur la chaîne de blocs. Le grand livre de la chaîne de blocs est mise à jour à la suite de chaque transaction de données et une nouvelle référence didentité numérique ou des clés chiffrées pour le dispositif IDO sont émises à la suite de chaque transaction. La méthode comprend également la réception dune instruction opérationnelle à partir dun dispositif frontal et une authentification de la part du dossier de la chaîne de blocs, de la référence didentité numérique, les permissions dutilisateur et la validité des paramètres dune opération, en fonction des politiques dune organisation.
Patent CA-3131508-A1 (CA)
Title: Syringe with multifunctional needle holder and retainer ring assembly
Inventor: ZHU NI
IPC: A61M5/34
Filed: 2019-09-19
Abstract: A syringe for medical use, the syringe having a selectively retractable needle and a multifunctional needle holder and retainer ring assembly including a needle holder with a head section having an inwardly tapering frustoconical section of the fluid pathway and a rearwardly facing annular surface surrounding the rear opening, and an elastomeric retainer ring with a substantially unexpanded collar extending rearwardly beyond the rearwardly facing annular surface to increase needle pushout force, reduce activation force and improve fluid flow through the syringe. Annular projections inside the retainer ring and on the outer surface of the head section of the needle holder are also disclosed.
Patent CA-3131619-A1 (CA)
Title: Self-stabilizing linker conjugates
Inventor: LYON ROBERT
IPC: A61K47/68
Filed: 2013-05-14
Abstract: The present invention provides Ligand-Drug Conjugates, Drug-Linkers, Linkers, and Ligand-Linker Conjugates comprising a self-stabilizing linker assembly component.  Antibody drug conjugates are for example provided, having the formula:    wherein D is a Drug unit; Ab is an antibody; 1\4' is a succinimide or hydrolyzed succinimide; BU  is a Basic unit; and L  is a bond or a secondary linker assembly unit.
Patent CA-3135187-A1 (CA)
Title: Mowers, mower deck mount systems, and methods
Inventor: DINGMAN TRENT J
IPC: A01D34/64
Filed: 2021-10-19
Abstract: Lawn mowers and methods associated therewith. A lawn mower can include a frame; and mounting hardware configured to couple the frame to a detachable mower deck, wherein the mounting hardware comprises: a quick release engagement interface; and a latched interface, the latched interface comprising a self-closing latch and an engageable interface to permit selective opening of the self-closing latch.
Patent CA-3136113-A1 (CA)
Inventor: SUH WONCHUL
IPC: C12N9/22
Filed: 2020-04-03
Abstract: Methods and compositions are provided for integrating genes of interest into the genome of a Bacillus sp. cell without the integration of a selectable marker into said genome. The methods employ a dual circular recombinant DNA system for introduction of a guide RNA/Cas endonuclease system (also referred to as an RNA guided endonuclease, RGEN) as well as a donor DNA into a Bacillus sp. cell, and providing a highly effective system for inserting genes of interest into the genome of said Bacillus sp. cell.
Patent CA-3139311-A1 (CA)
Title: System and method for ledger analytics and application of digital tax stamps
Inventor: ZAFAR FAWAD
IPC: G06Q40/00
Filed: 2020-05-29
Abstract: The invention relates to systems, methods, and computer program media for the analysis of ledger entries relating to the transfer of assets, potentially among disparate jurisdictions, and real-time accounting for tax liabilities resulting from such transfers, and displaying the results of such analysis. The invention provides improved accounting and payment of taxes for transfer pricing, cross-border transactions, sales taxes and VAT taxes, as well as taxes on accrued asset values. The invention involves the analysis of transactions between entities, where the assets transferred among the transacting entities have changing market values, and where the entities may be subject to differing tax regimes. The invention further provides verification of payment of taxes by the use of digital tax stamps that are generated through the allocation of funds for the payment of taxes, by the payment of taxes, or are received from a tax authority in response to the payment of taxes.